Back to Companies
VERTEX PHARMACEUTICALS INC / MA
VRTXNasdaqCIK: 0000875320
Over the 50 most recent insider filings, VERTEX PHARMACEUTICALS INC / MA (VRTX) has seen activity from 20 distinct insiders — all of them on the sell side. The activity is heavily weighted toward selling: $0 bought versus $46.8M sold, net sales of $46.8M. Sachdev Amit (EVP Chief Patient & Ext Af Off) is the most active by dollar volume, and the single largest transaction was $44.2M by Sachdev Amit. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$92.8M
Purchases
$0
Sales
$46.8M
Unique Insiders
20
Recent Insider Trades
50 loaded
| Jul 23 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Grant | $0 |
| Jul 23 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | Grant | $0 |
| Jul 17 | VRTX VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Director | Award | $0 |
| Jul 17 | VRTX VERTEX PHARMACEUTICALS INC / MA | Garber Alan M | Director | Award | $0 |
| Jul 7 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | $787.5K |
| Jul 7 | VRTX VERTEX PHARMACEUTICALS INC / MA | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | $799.8K |
| Jul 6 | VRTX VERTEX PHARMACEUTICALS INC / MA | Liu Joy | EVP and Chief Legal Officer | Sell | $416.2K |
| Jun 30 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Sell | $287.6K |
| Jun 23 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Sell | $471.4K |
| Jun 17 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Sell | $1.8M |
| Jun 9 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Sell | $785.3K |
| Jun 3 | VRTX VERTEX PHARMACEUTICALS INC / MA | Liu Joy | EVP and Chief Legal Officer | Sell | $364.2K |
| Jun 2 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Sell | $888.3K |
| May 19 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | $15.0K |
| May 19 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Sell | $614.0K |
| May 14 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Sell | $3.1M |
| May 5 | VRTX VERTEX PHARMACEUTICALS INC / MA | MCKENZIE DIANA | Director | Grant | $0 |
| May 5 | VRTX VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Director | Award | $1.2M |
| May 5 | VRTX VERTEX PHARMACEUTICALS INC / MA | Thornberry Nancy | Director | Grant | $608.2K |
| May 5 | VRTX VERTEX PHARMACEUTICALS INC / MA | Lagarde Michel | Director | Award | $1.2M |
| May 5 | VRTX VERTEX PHARMACEUTICALS INC / MA | Upadhyay Suketu | Director | Award | $1.2M |
| May 5 | VRTX VERTEX PHARMACEUTICALS INC / MA | Liu Joy | EVP and Chief Legal Officer | Sell | $469.2K |
| May 5 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bhatia Sangeeta N. | Director | Sell | $134.7K |
| May 5 | VRTX VERTEX PHARMACEUTICALS INC / MA | Schneider Jennifer | Director | Grant | $608.2K |
| May 5 | VRTX VERTEX PHARMACEUTICALS INC / MA | Garber Alan M | Director | Grant | $608.2K |
| Apr 17 | VRTX VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Director | Award | $0 |
| Apr 17 | VRTX VERTEX PHARMACEUTICALS INC / MA | Upadhyay Suketu | Director | Award | $0 |
| Apr 3 | VRTX VERTEX PHARMACEUTICALS INC / MA | Liu Joy | EVP and Chief Legal Officer | Sell | $439.3K |
| Mar 31 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Sell | $1.1M |
| Mar 4 | VRTX VERTEX PHARMACEUTICALS INC / MA | Liu Joy | EVP and Chief Legal Officer | Sell | $442.4K |
| Mar 3 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Sell | $1.1M |
| Mar 2 | VRTX VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | $172.6K |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | $126.5K |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman, Director | Tax withheld | $1.7M |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR | EVP, CO & FO | Tax withheld | $846.0K |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Tax withheld | $2.4M |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | Sell | $108.5K |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | Biller Jonathan | EVP and Chief Legal Officer | Sell | $459.6K |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell | $324.9K |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | McKechnie Duncan | EVP, Chief Commercial Officer | Sell | $2.4M |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | $897.8K |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Tax withheld | $704.9K |
| Feb 26 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell | $301.5K |
| Feb 23 | VRTX VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell | $27.5M |
| Feb 19 | VRTX VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell | $472.4K |
| Feb 19 | VRTX VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Grant | $924.9K |
| Feb 19 | VRTX VERTEX PHARMACEUTICALS INC / MA | McKechnie Duncan | EVP, Chief Commercial Officer | Grant | $555.3K |
| Feb 19 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Grant | $3.2M |
| Feb 18 | VRTX VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President, Director | Tax withheld | $6.4M |
| Feb 18 | VRTX VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR | EVP, CO & FO | Tax withheld | $2.2M |
50 filings+